Hippo signaling

pathway activity — cross-omics
GO:0035329Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Hippo signaling pathway is significantly associated with the RNA expression of multiple genes, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CDH3, LAYN, and TES, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Hippo signaling activity versus CDH3 in OV (Pearson r = 0.30).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVCDH3 →+1.258+0.286<.001.00535
LUADLAYN →+0.581+0.410.001.00235
BRCATES →+0.668+0.451.004.00634
UCECMYO1H →+0.304+0.685.006.00834
GBMEVA1A →+0.923+0.640.002.00134
GBMBICC1 →+0.804+0.572.001.00434
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0035329 vs CDH3 — OV

Per-sample scatter of Hippo signaling activity vs CDH3 in OV.

Explore this scatter interactively →

Exploration